{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:09:24Z","timestamp":1790770164821,"version":"4.1.0"},"reference-count":52,"publisher":"American Society of Hematology","issue":"8","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2003,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Immunoglobulin variable heavy chain gene (VH) mutation status and VDJ rearrangement structure were analyzed in 141 patients with mantle cell lymphoma (MCL) and correlated with biologic and clinical characteristics; 29% of the MCLs displayed mutated VH using a 98% germline homology cutoff. Striking differences occurred in the VH mutation subgroups with respect to the use of specific V genes. Rearrangements involving V4-34 and V3-21 were almost exclusively unmutated, whereas rearrangements using V4-59 and V3-23 were typically mutated. Significant association occurred between mutated VH with shorter CDR3 lengths and the use of JH4b. V3-21 and V4-59 were involved in highly characteristic rearrangements, implying that antigen specificity might have been involved in MCL development. There was no evidence for isotype switch recombination or Bcl-6 expression in any MCL. ZAP70 expression was not different in VH-mutated or -unmutated MCL. Although the deletions 11q\u2013 and 17p\u2013 showed a balanced distribution, an overrepresentation was observed for trisomies +3q, +8q, and tetraploidy in the VH-unmutated subgroup and +12q in the VH-mutated subgroup. Clinically, mutated VH was associated with a higher rate of complete remission, but there was no correlation between VH mutation status and other clinical characteristics or overall survival.<\/jats:p>","DOI":"10.1182\/blood-2003-05-1383","type":"journal-article","created":{"date-parts":[[2003,7,8]],"date-time":"2003-07-08T00:23:14Z","timestamp":1057623794000},"page":"3003-3009","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":120,"title":["VH mutation status and VDJ rearrangement structure in mantle cell lymphoma: correlation with genomic aberrations, clinical characteristics, and outcome"],"prefix":"10.1182","volume":"102","author":[{"given":"Dirk","family":"Kienle","sequence":"first","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Kro\u0308ber","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiemo","family":"Katzenberger","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"German","family":"Ott","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Leupolt","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F. E.","family":"Barth","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mo\u0308ller","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Benner","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annett","family":"Habermann","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans Konrad","family":"Mu\u0308ller-Hermelink","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bentz","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Lichter","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut","family":"Do\u0308hner","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[{"name":"From the Departments of Internal Medicine III and Pathology, University of Ulm, Germany; the Department of Pathology, University of Wu\u0308rzburg, Germany; and the Departments of Biostatistics and Molecular Genetics, Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021219035600100_REF1","doi-asserted-by":"crossref","unstructured":"Argatoff LH, Connors JM, Klasa RJ, Horsman DE, Gascoyne RD. Mantle cell lymphoma: a clinicopathologic study of 80 cases. Blood. 1997;89: 2067-2078.","DOI":"10.1182\/blood.V89.6.2067"},{"key":"2020021219035600100_REF2","doi-asserted-by":"crossref","unstructured":"Bosch F, Lopez-Guillermo A, Campo E, et al. Mantle cell lymphoma: presenting features, response to therapy, and prognostic factors. Cancer. 1998;82: 567-575.","DOI":"10.1002\/(SICI)1097-0142(19980201)82:3<567::AID-CNCR20>3.0.CO;2-Z"},{"key":"2020021219035600100_REF3","unstructured":"Campo E, Raffeld M, Jaffe ES. Mantle-cell lymphoma. Semin Hematol. 1999;36: 115-127."},{"key":"2020021219035600100_REF4","doi-asserted-by":"crossref","unstructured":"Tsujimoto Y, Yunis J, Onorato-Showe L, Erikson J, Nowell PC, Croce CM. Molecular cloning of the chromosomal breakpoint of B-cell lymphomas and leukemias with the t(11;14) chromosome translocation. Science. 1984;224: 1403-1406.","DOI":"10.1126\/science.6610211"},{"key":"2020021219035600100_REF5","doi-asserted-by":"crossref","unstructured":"Rosenberg CL, Wong E, Petty EM, et al. PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci U S A. 1991;88: 9638-9642.","DOI":"10.1073\/pnas.88.21.9638"},{"key":"2020021219035600100_REF6","unstructured":"Williams ME, Swerdlow SH, Meeker TC. Chromosome t(11;14)(q13;q32) breakpoints in centrocytic lymphoma are highly localized at the bcl-1 major translocation cluster. Leukemia. 1993;7: 1437-1440."},{"key":"2020021219035600100_REF7","doi-asserted-by":"crossref","unstructured":"Monni O, Oinonen R, Elonen E, et al. Gain of 3q and deletion of 11q22 are frequent aberrations in mantle cell lymphoma. Genes Chromosomes Cancer. 1998;21: 298-307.","DOI":"10.1002\/(SICI)1098-2264(199804)21:4<298::AID-GCC3>3.0.CO;2-U"},{"key":"2020021219035600100_REF8","unstructured":"Bea S, Ribas M, Hernandez JM, et al. Increased number of chromosomal imbalances and high-level DNA amplifications in mantle cell lymphoma are associated with blastoid variants. Blood. 1999;93: 4365-4374."},{"key":"2020021219035600100_REF9","doi-asserted-by":"crossref","unstructured":"Bentz M, Plesch A, Bullinger L, et al. t(11;14)-positive mantle cell lymphomas exhibit complex karyotypes and share similarities with B-cell chronic lymphocytic leukemia. Genes Chromosomes Cancer. 2000;27: 285-294.","DOI":"10.1002\/(SICI)1098-2264(200003)27:3<285::AID-GCC9>3.0.CO;2-M"},{"key":"2020021219035600100_REF10","doi-asserted-by":"crossref","unstructured":"Louie DC, Offit K, Jaslow R, et al. p53 overexpression as a marker of poor prognosis in mantle cell lymphomas with t(11;14)(q13;q32). Blood. 1995;86: 2892-2899.","DOI":"10.1182\/blood.V86.8.2892.2892"},{"key":"2020021219035600100_REF11","doi-asserted-by":"crossref","unstructured":"Hernandez L, Fest T, Cazorla M, et al. p53 gene mutations and protein overexpression are associated with aggressive variants of mantle cell lymphomas. Blood. 1996;87: 3351-3359.","DOI":"10.1182\/blood.V87.8.3351.bloodjournal8783351"},{"key":"2020021219035600100_REF12","doi-asserted-by":"crossref","unstructured":"Greiner TC, Moynihan MJ, Chan WC, et al. p53 mutations in mantle cell lymphoma are associated with variant cytology and predict a poor prognosis. Blood. 1996;87: 4302-4310.","DOI":"10.1182\/blood.V87.10.4302.bloodjournal87104302"},{"key":"2020021219035600100_REF13","doi-asserted-by":"crossref","unstructured":"Pinyol M, Hernandez L, Cazorla M, et al. Deletions and loss of expression of p16INK4a and p21Waf1 genes are associated with aggressive variants of mantle cell lymphomas. Blood. 1997; 89: 272-280.","DOI":"10.1182\/blood.V89.1.272"},{"key":"2020021219035600100_REF14","unstructured":"Dreyling MH, Bullinger L, Ott G, et al. Alterations of the cyclin D1\/p16-pRB pathway in mantle cell lymphoma. Cancer Res. 1997;57: 4608-4614."},{"key":"2020021219035600100_REF15","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Wright G, Wiestner A, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 2003;3: 185-197.","DOI":"10.1016\/S1535-6108(03)00028-X"},{"key":"2020021219035600100_REF16","doi-asserted-by":"crossref","unstructured":"Daniel MT, Tigaud I, Flexor MA, Nogueira ME, Berger R, Jonveaux P. Leukaemic non-Hodgkin's lymphomas with hyperdiploid cells and t(11; 14)(q13;q32): a subtype of mantle cell lymphoma? Br J Haematol. 1995;90: 77-84.","DOI":"10.1111\/j.1365-2141.1995.tb03383.x"},{"key":"2020021219035600100_REF17","doi-asserted-by":"crossref","unstructured":"Ott G, Kalla J, Ott MM, et al. Blastoid variants of mantle cell lymphoma: frequent bcl-1 rearrangements at the major translocation cluster region and tetraploid chromosome clones. Blood. 1997; 89: 1421-1429.","DOI":"10.1182\/blood.V89.4.1421"},{"key":"2020021219035600100_REF18","doi-asserted-by":"crossref","unstructured":"Camacho E, Hernandez L, Hernandez S, et al. ATM gene inactivation in mantle cell lymphoma mainly occurs by truncating mutations and mis-sense mutations involving the phosphatidylinositol-3 kinase domain and is associated with increasing numbers of chromosomal imbalances. Blood. 2002;99: 238-244.","DOI":"10.1182\/blood.V99.1.238"},{"key":"2020021219035600100_REF19","doi-asserted-by":"crossref","unstructured":"Stilgenbauer S, Winkler D, Ott G, et al. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood. 1999;94: 3262-3264.","DOI":"10.1182\/blood.V94.9.3262"},{"key":"2020021219035600100_REF20","doi-asserted-by":"crossref","unstructured":"Schaffner C, Idler I, Stilgenbauer S, Do\u0308hner H, Lichter P. Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci U S A. 2000;97: 2773-2778.","DOI":"10.1073\/pnas.050400997"},{"key":"2020021219035600100_REF21","doi-asserted-by":"crossref","unstructured":"Ku\u0308ppers R, Klein U, Hansmann ML, Rajewsky K. Cellular origin of human B-cell lymphomas. N Engl J Med. 1999;341: 1520-1529.","DOI":"10.1056\/NEJM199911113412007"},{"key":"2020021219035600100_REF22","doi-asserted-by":"crossref","unstructured":"Frater JL, Hsi ED. Properties of the mantle cell and mantle cell lymphoma. Curr Opin Hematol. 2002;9: 56-62.","DOI":"10.1097\/00062752-200201000-00010"},{"key":"2020021219035600100_REF23","doi-asserted-by":"crossref","unstructured":"Thorselius M, Walsh S, Eriksson I, et al. Somatic hypermutation and V(H) gene usage in mantle cell lymphoma. Eur J Haematol. 2002;68: 217-224.","DOI":"10.1034\/j.1600-0609.2002.01662.x"},{"key":"2020021219035600100_REF24","doi-asserted-by":"crossref","unstructured":"Orchard J, Garand R, Davis Z, et al. A subset of t(11;14) lymphoma with mantle cell features displays mutated IgVH genes and includes patients with good prognosis, nonnodal disease. Blood. 2003;101: 4975-4981.","DOI":"10.1182\/blood-2002-06-1864"},{"key":"2020021219035600100_REF25","doi-asserted-by":"crossref","unstructured":"Camacho FI, Algara P, Rodriguez A, et al. Molecular heterogeneity in MCL defined by the use of specific VH genes and the frequency of somatic mutations. Blood. 2003;101: 4042-4046.","DOI":"10.1182\/blood-2002-11-3456"},{"key":"2020021219035600100_REF26","doi-asserted-by":"crossref","unstructured":"Walsh SH, Thorselius M, Johnson A, et al. Mutated VH genes and preferential VH3-21 usage define new subsets of mantle cell lymphoma. Blood. 2003;101: 4047-4054.","DOI":"10.1182\/blood-2002-11-3479"},{"key":"2020021219035600100_REF27","unstructured":"Kienle D, Kro\u0308ber A, Leupolt E, et al. VH mutation status and gene usage in mantle cell lymphoma: correlation with genomic aberrations and survival [abstract]. Blood. 2002;100: 331."},{"key":"2020021219035600100_REF28","doi-asserted-by":"crossref","unstructured":"Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94: 1840-1847.","DOI":"10.1182\/blood.V94.6.1840"},{"key":"2020021219035600100_REF29","doi-asserted-by":"crossref","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94: 1848-1854.","DOI":"10.1182\/blood.V94.6.1848"},{"key":"2020021219035600100_REF30","doi-asserted-by":"crossref","unstructured":"Rosenwald A, Alizadeh AA, Widhopf G, et al. Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia. J Exp Med. 2001;194: 1639-1647.","DOI":"10.1084\/jem.194.11.1639"},{"key":"2020021219035600100_REF31","doi-asserted-by":"crossref","unstructured":"Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med. 2001;194: 1625-1638.","DOI":"10.1084\/jem.194.11.1625"},{"key":"2020021219035600100_REF32","doi-asserted-by":"crossref","unstructured":"Chen L, Widhopf G, Huynh L, et al. Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. Blood. 2002;100: 4609-4614.","DOI":"10.1182\/blood-2002-06-1683"},{"key":"2020021219035600100_REF33","doi-asserted-by":"crossref","unstructured":"Wiestner A, Rosenwald A, Barry TS, et al. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile. Blood. 2003;101: 4944-4951.","DOI":"10.1182\/blood-2002-10-3306"},{"key":"2020021219035600100_REF34","doi-asserted-by":"crossref","unstructured":"Kro\u0308ber A, Seiler T, Benner A, et al. VH mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia. Blood. 2002;100: 1410-1418.","DOI":"10.1182\/blood.V100.4.1410.h81602001410_1410_1416"},{"key":"2020021219035600100_REF35","doi-asserted-by":"crossref","unstructured":"Lin K, Sherrington PD, Dennis M, Matrai Z, Cawley JC, Pettitt AR. Relationship between p53 dysfunction, CD38 expression, and IgV(H) mutation in chronic lymphocytic leukemia. Blood. 2002; 100: 1404-1409.","DOI":"10.1182\/blood-2001-11-0066"},{"key":"2020021219035600100_REF36","doi-asserted-by":"crossref","unstructured":"Oscier DG, Gardiner AC, Mould SJ, et al. Multivariate analysis of prognostic factors in CLL: clinical stage, IgVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors. Blood. 2002;100: 1177-1184.","DOI":"10.1182\/blood.V100.4.1177.h81602001177_1177_1184"},{"key":"2020021219035600100_REF37","doi-asserted-by":"crossref","unstructured":"Do\u0308hner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med. 2000;343: 1910-1916.","DOI":"10.1056\/NEJM200012283432602"},{"key":"2020021219035600100_REF38","doi-asserted-by":"crossref","unstructured":"Corbett SJ, Tomlinson IM, Sonnhammer EL, Buck D, Winter G. Sequence of the human immunoglobulin diversity (D) segment locus: a systematic analysis provides no evidence for the use of DIR segments, inverted D segments, \u201cminor\u201d D segments or D-D recombination. J Mol Biol. 1997; 270: 587-597.","DOI":"10.1006\/jmbi.1997.1141"},{"key":"2020021219035600100_REF39","doi-asserted-by":"crossref","unstructured":"Fais F, Ghiotto F, Hashimoto S, et al. Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. J Clin Invest. 1998;102: 1515-1525.","DOI":"10.1172\/JCI3009"},{"key":"2020021219035600100_REF40","doi-asserted-by":"crossref","unstructured":"Falini B, Fizzotti M, Pileri S, Liso A, Pasqualucci L, Flenghi L. Bcl-6 protein expression in normal and neoplastic lymphoid tissues. Ann Oncol. 1997;8(suppl 2): 101-104.","DOI":"10.1093\/annonc\/8.suppl_2.S101"},{"key":"2020021219035600100_REF41","unstructured":"Flenghi L, Bigerna B, Fizzotti M, et al. Monoclonal antibodies PG-B6a and PG-B6p recognize, respectively, a highly conserved and a formol-resistant epitope on the human BCL-6 protein amino-terminal region. Am J Pathol. 1996;148: 1543-1555."},{"key":"2020021219035600100_REF42","doi-asserted-by":"crossref","unstructured":"Korz C, Pscherer A, Benner A, et al. Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes. Blood. 2002;99: 4554-4561.","DOI":"10.1182\/blood.V99.12.4554"},{"key":"2020021219035600100_REF43","unstructured":"Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6: 65-70."},{"key":"2020021219035600100_REF44","doi-asserted-by":"crossref","unstructured":"Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graphical Stat. 1996;5: 299-314.","DOI":"10.1080\/10618600.1996.10474713"},{"key":"2020021219035600100_REF45","doi-asserted-by":"crossref","unstructured":"Brezinschek HP, Foster SJ, Brezinschek RI, Dorner T, Domiati-Saad R, Lipsky PE. Analysis of the human VH gene repertoire: differential effects of selection and somatic hypermutation on human peripheral CD5(+)\/IgM+ and CD5(\u2013)\/IgM+ B cells. J Clin Invest. 1997;99: 2488-2501.","DOI":"10.1172\/JCI119433"},{"key":"2020021219035600100_REF46","unstructured":"Kro\u0308ber A, Benner A, Bu\u0308hler A, Do\u0308hner H, Stilgenbauer S. Multivariate survival analysis of specific VH genes in CLL: V3-21 and V3-23 are prognostic factors independently of the VH mutation status [abstract]. Blood. 2002;100: 738."},{"key":"2020021219035600100_REF47","doi-asserted-by":"crossref","unstructured":"Lossos IS, Okada CY, Tibshirani R, et al. Molecular analysis of immunoglobulin genes in diffuse large B-cell lymphomas. Blood. 2000;95: 1797-1803.","DOI":"10.1182\/blood.V95.5.1797.005k30_1797_1803"},{"key":"2020021219035600100_REF48","unstructured":"Ku\u0308ppers R. Ongoing somatic mutation in mantle cell lymphomas questioned. Br J Haematol. 1997; 97: 932-934."},{"key":"2020021219035600100_REF49","doi-asserted-by":"crossref","unstructured":"Crespo M, Bosch F, Villamor N, et al. ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med. 2003;348: 1764-1775.","DOI":"10.1056\/NEJMoa023143"},{"key":"2020021219035600100_REF50","doi-asserted-by":"crossref","unstructured":"Tobin G, Thunberg U, Johnson A, et al. Somatically mutated Ig V(H)3-21 genes characterize a new subset of chronic lymphocytic leukemia. Blood. 2002;99: 2262-2264.","DOI":"10.1182\/blood.V99.6.2262"},{"key":"2020021219035600100_REF51","doi-asserted-by":"crossref","unstructured":"Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM. Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J. 1994;13: 2124-2130.","DOI":"10.1002\/j.1460-2075.1994.tb06488.x"},{"key":"2020021219035600100_REF52","doi-asserted-by":"crossref","unstructured":"Lovec H, Grzeschiczek A, Kowalski MB, Moroy T. Cyclin D1\/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice. EMBO J. 1994;13: 3487-3495.","DOI":"10.1002\/j.1460-2075.1994.tb06655.x"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/8\/3003\/1692125\/h82003003003.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/102\/8\/3003\/1692125\/h82003003003.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T04:42:26Z","timestamp":1734064946000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/102\/8\/3003\/17748\/VH-mutation-status-and-VDJ-rearrangement-structure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10,15]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2003,10,15]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2003-05-1383","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,10,15]]}}}